# PROTOCOL v12.0 ‚Äî –ü–û–õ–ù–´–ô –ê–£–î–ò–¢ –°–¢–ï–ö–ê

**–î–∞—Ç–∞:** 2026-01-22
**–¶–∏–∫–ª:** CYCLE-0002
**–í–µ—Ä–¥–∏–∫—Ç:** üî¥ –°–¢–û–ü ‚Äî –î–ò–ê–ì–ù–û–°–¢–ò–ß–ï–°–ö–ò–ô –¶–ò–ö–õ
**–ì–æ—Ä–∏–∑–æ–Ω—Ç –ø—Ä–æ–≤–µ—Ä–∫–∏:** 4 –Ω–µ–¥–µ–ª–∏ (–ø–æ—Å–ª–µ –∞–Ω–∞–ª–∏–∑–æ–≤)

---

## 1. –û–ë–ó–û–†

### –û–°–ù–û–í–ù–´–ï –¶–ï–õ–ò

| –¶–µ–ª—å | –¢–µ–∫—É—â–µ–µ | –¶–µ–ª–µ–≤–æ–µ | –°—Ç—Ä–∞—Ç–µ–≥–∏—è | –ü—Ä–∏–æ—Ä–∏—Ç–µ—Ç |
|------|---------|---------|-----------|-----------|
| –ö–æ–≥–Ω–∏—Ç–∏–≤–∫–∞ (–ø–∞–º—è—Ç—å, —Ä–µ—á—å) | 3/10 | 9/10 | Yale –ø—Ä–æ—Ç–æ–∫–æ–ª + –Ω–µ–π—Ä–æ–ø–µ–ø—Ç–∏–¥—ã + MAO-—Å—Ç–µ–∫ | üî¥ –ö–†–ò–¢–ò–ß–ù–û |
| –ú–æ—Ç–∏–≤–∞—Ü–∏—è/–∞–Ω–≥–µ–¥–æ–Ω–∏—è | 4/10 | 9/10 | NOR-BNI + MAO-—Å—Ç–µ–∫ + DA-–ø—Ä–µ–∫—É—Ä—Å–æ—Ä—ã | üî¥ –ö–†–ò–¢–ò–ß–ù–û |
| –ì–ª—É–±–æ–∫–∏–π —Å–æ–Ω | 15-20% | >25% | –û–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è —Å–æ–Ω-—Å—Ç–µ–∫–∞ + –æ—Ç–º–µ–Ω–∞ –º–µ—à–∞—é—â–∏—Ö | üî¥ –ö–†–ò–¢–ò–ß–ù–û |
| –¢—É–º–∞–Ω –≤ –≥–æ–ª–æ–≤–µ (Long COVID) | 6/10 | 1/10 | LDN + MCAS + —Ñ–µ—Ä–º–µ–Ω—Ç—ã + MB | üî¥ –ö–†–ò–¢–ò–ß–ù–û |
| –õ–µ–ø—Ç–∏–Ω | <0.5 –Ω–≥/–º–ª | >3 –Ω–≥/–º–ª | ~~–°—É–≥–ª–∞—Ç~~ –û–¢–ú–ï–ù–Å–ù + –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ | üî¥ –ö–†–ò–¢–ò–ß–ù–û |
| Body Fat % | 18-20% | 9-10% | ~~–°—É–≥–ª–∞—Ç~~ + ~~IF~~ –û–¢–ú–ï–ù–ï–ù–´ + RC-—Å—Ç–µ–∫ | üü† –í–´–°–û–ö–ò–ô |
| –ú—ã—à–µ—á–Ω–∞—è –º–∞—Å—Å–∞ | 77 –∫–≥ LBM | 82+ –∫–≥ LBM | –ì–ó–¢ + –ì–† + —Ç—Ä–µ–Ω–∏—Ä–æ–≤–∫–∏ + –ø–µ–ø—Ç–∏–¥—ã | üü° –°–†–ï–î–ù–ò–ô |
| Longevity | ‚Äî | –ú–∞–∫—Å. | –†–∞–ø–∞–º–∏—Ü–∏–Ω + FOXO4-DRI + —Å–µ–Ω–æ–ª–∏—Ç–∏–∫–∏ | üü¢ –§–û–ù–û–í–´–ô |

### –ö–õ–Æ–ß–ï–í–´–ï –ü–†–û–ë–õ–ï–ú–´

| –ü—Ä–æ–±–ª–µ–º–∞ | –ü—Ä–∏—á–∏–Ω–∞ | –†–µ—à–µ–Ω–∏–µ | –°—Ç–∞—Ç—É—Å | –ü—Ä–∏–æ—Ä–∏—Ç–µ—Ç |
|----------|---------|---------|--------|-----------|
| Long COVID 3 –≥–æ–¥–∞ | Spike-–ø—Ä–æ—Ç–µ–∏–Ω, –Ω–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ | LDN + MCAS + —Ñ–µ—Ä–º–µ–Ω—Ç—ã + Yale | –í –ø—Ä–æ—Ü–µ—Å—Å–µ | üî¥ |
| –ì–∏–ø–æ—Ç–∞–ª–∞–º–∏—á–µ—Å–∫–∞—è –¥–∏—Å—Ñ—É–Ω–∫—Ü–∏—è | –ü–æ—Å—Ç–∫–æ–≤–∏–¥–Ω–∞—è | –†–∞–ø–∞–º–∏—Ü–∏–Ω + VIP + –≥—É–∞–Ω—Ñ–∞—Ü–∏–Ω | –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è | üî¥ |
| –ö—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –Ω–∏–∑–∫–∏–π –ª–µ–ø—Ç–∏–Ω | TRT + ~~SGLT2~~ | –û—Ç–º–µ–Ω–∞ –°—É–≥–ª–∞—Ç–∞ + –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ | **–ò–ó–ú–ï–ù–ï–ù–û** | üî¥ |
| –ü—Ä–æ–±–ª–µ–º—ã —Å —Ä–µ—á—å—é/–ø–∞–º—è—Ç—å—é | Long COVID –Ω–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ | –ù–µ–π—Ä–æ–ø–µ–ø—Ç–∏–¥—ã + MAO-—Å—Ç–µ–∫ | –í –ø—Ä–æ—Ü–µ—Å—Å–µ | üî¥ |
| –ú–∞–ª–æ –≥–ª—É–±–æ–∫–æ–≥–æ —Å–Ω–∞ | –ú–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ + —Å—Ç—Ä–µ—Å—Å | –û–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è –≤–µ—á–µ—Ä–Ω–µ–≥–æ —Å—Ç–µ–∫–∞ | –í –ø—Ä–æ—Ü–µ—Å—Å–µ | üî¥ |
| –ö–æ–∂–Ω—ã–µ –ø—Ä–æ–±–ª–µ–º—ã (HS) | –ò–º–º—É–Ω–Ω–æ–µ –≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ | MCAS-–ø—Ä–æ—Ç–æ–∫–æ–ª | –í –ø—Ä–æ—Ü–µ—Å—Å–µ | üü° |
| **–ù–û–í–û–ï: –ü–æ–ª–∏–ø—Ä–∞–≥–º–∞–∑–∏—è** | 45+ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –µ–∂–µ–¥–Ω–µ–≤–Ω–æ | –î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ ‚Üí —É–ø—Ä–æ—â–µ–Ω–∏–µ | –í—ã—è–≤–ª–µ–Ω–æ | üî¥ |
| **–ù–û–í–û–ï: –°—Ç—Ä–∞—Ç–µ–≥–∏—è –Ω–µ —Ä–∞–±–æ—Ç–∞–µ—Ç** | 3 –≥–æ–¥–∞ –±–µ–∑ —É–ª—É—á—à–µ–Ω–∏—è | –ü–µ—Ä–µ—Å–º–æ—Ç—Ä –ø–æ–¥—Ö–æ–¥–∞ | –í—ã—è–≤–ª–µ–Ω–æ | üî¥ |

---

## 2. –ü–û–õ–ù–´–ô –°–¢–ï–ö

### –£–¢–†–ï–ù–ù–ò–ô –ë–õ–û–ö (5:00-8:00)

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –î–æ–∑–∞ | –í—Ä–µ–º—è | –ú–µ—Ö–∞–Ω–∏–∑–º | –¶–µ–ª—å | –°—Ç–∞—Ç—É—Å |
|----------|------|-------|----------|------|--------|
| –ì–† (Genotropin) | 5 IU | 5:00 | GH‚ÜíIGF-1, –ª–∏–ø–æ–ª–∏–∑ | –†–µ–∫–æ–º–ø–æ–∑–∏—Ü–∏—è, longevity | ‚úÖ |
| MB (–º–µ—Ç–∏–ª–µ–Ω–æ–≤—ã–π —Å–∏–Ω–∏–π) | 15-20 –º–≥ | 7:30 | –ú–∏—Ç–æ—Ö–æ–Ω–¥—Ä–∏–∏, –∞–Ω—Ç–∏–≤–∏—Ä—É—Å | Long COVID, –∫–æ–≥–Ω–∏—Ç–∏–≤–∫–∞ | ‚úÖ |
| ADCAPR | 50 –º–≥ | 7:30 | DA + NE + AMPA –º–æ–¥—É–ª—è—Ü–∏—è | –ú–æ—Ç–∏–≤–∞—Ü–∏—è, —Ñ–æ–∫—É—Å | ‚úÖ |
| –ú–æ–∫–ª–æ–±–µ–º–∏–¥ | 150 –º–≥ | 7:30 | MAO-A RIMA | DA/NE/5-HT ‚Üë | ‚úÖ |
| D-Phenylalanine | 700 –º–≥ | 7:30 | PEA –ø—Ä–µ–∫—É—Ä—Å–æ—Ä | –° MAO = –¥–ª–∏—Ç–µ–ª—å–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç | ‚úÖ |
| Meclofenoxate | 300 –º–≥ | 7:30 | ACh + –∞–Ω—Ç–∏–ª–∏–ø–æ—Ñ—É—Å—Ü–∏–Ω | –ü–∞–º—è—Ç—å, –Ω–µ–π—Ä–æ–ø—Ä–æ—Ç–µ–∫—Ü–∏—è | ‚úÖ |
| Eutropoflavin | 10 –º–≥ | 7:30 | TrkB –∞–≥–æ–Ω–∏—Å—Ç ‚Üí BDNF | –ù–µ–π—Ä–æ—Ä–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏—è | ‚úÖ |
| Ibudilast | 10 –º–≥ | 7:30 | PDE4/–≥–ª–∏—è –∏–Ω–≥–∏–±–∏—Ç–æ—Ä | –ù–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ Long COVID | ‚úÖ |
| Mg L-Threonate | 1000 –º–≥ | 7:30 | Mg –≤ –º–æ–∑–≥ | –ö–æ–≥–Ω–∏—Ç–∏–≤–∫–∞, –Ω–µ–π—Ä–æ–ø—Ä–æ—Ç–µ–∫—Ü–∏—è | ‚úÖ |
| Ac-Semax-NH2 | 300-600 –º–∫–≥ | 7:30 | BDNF ‚Üë, NGF ‚Üë | –ö–æ–≥–Ω–∏—Ç–∏–≤–∫–∞, –Ω–µ–π—Ä–æ—Ä–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏—è | ‚úÖ |
| Dihexa | 1-2 –º–≥ | 7:30 | HGF/c-Met ‚Üí —Å–∏–Ω–∞–ø—Ç–æ–≥–µ–Ω–µ–∑ | –ü–∞–º—è—Ç—å (–∫—É—Ä—Å–∞–º–∏) | ‚úÖ |
| PE-22-28 | 500 –º–∫–≥ | 7:30 | 5-HT4 ‚Üí BDNF | –ù–µ–π—Ä–æ–ø–ª–∞—Å—Ç–∏—á–Ω–æ—Å—Ç—å | ‚úÖ |
| –≠—Ä–∏—É—Å | 5 –º–≥ | 7:30 | H1 –±–ª–æ–∫–∞–¥–∞ | MCAS, Long COVID | ‚úÖ |
| –ù–∞—Ç—Ç–æ–∫–∏–Ω–∞–∑–∞ | 4000 FU | 7:30 | –§–∏–±—Ä–∏–Ω–æ–ª–∏–∑, spike | –†–∞–∑—Ä—É—à–µ–Ω–∏–µ spike-–ø—Ä–æ—Ç–µ–∏–Ω–∞ | ‚úÖ |
| –°–µ—Ä—Ä–∞–ø–µ–ø—Ç–∞–∑–∞ | 120000 SPU | 7:30 | –ü—Ä–æ—Ç–µ–æ–ª–∏–∑ | –†–∞–∑—Ä—É—à–µ–Ω–∏–µ spike, –≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ | ‚úÖ |
| –ë—Ä–æ–º–µ–ª–∞–π–Ω | 500 –º–≥ | 7:30 | –ü—Ä–æ—Ç–µ–æ–ª–∏–∑ | –°–∏–Ω–µ—Ä–≥–∏—è —Å NAC –¥–ª—è spike | ‚úÖ |
| NAC | 600 –º–≥ | 7:30 | –ì–ª—É—Ç–∞—Ç–∏–æ–Ω ‚Üë | –ê–Ω—Ç–∏–æ–∫—Å–∏–¥–∞–Ω—Ç, spike | ‚úÖ |
| –ö–≤–µ—Ä—Ü–µ—Ç–∏–Ω | 500 –º–≥ | 7:30 | Mast cell —Å—Ç–∞–±–∏–ª–∏–∑–∞—Ç–æ—Ä | MCAS + —Ü–∏–Ω–∫ –∏–æ–Ω–æ—Ñ–æ—Ä | ‚úÖ |
| ~~–°—É–≥–ª–∞—Ç (–∏–ø—Ä–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω)~~ | ~~50 –º–≥~~ | ~~7:30~~ | ~~SGLT2 ‚Üí –≥–ª—é–∫–æ–∑—É—Ä–∏—è~~ | ~~–ú–µ—Ç–∞–±–æ–ª–∏–∑–º, longevity~~ | ‚ùå **–£–ë–†–ê–ù** |
| NMN | 500-1000 –º–≥ | 7:30 | NAD+ –ø—Ä–µ–∫—É—Ä—Å–æ—Ä | Longevity, —ç–Ω–µ—Ä–≥–∏—è | ‚úÖ |
| –°–ø–µ—Ä–º–∏–¥–∏–Ω | 10-15 –º–≥ | 7:30 | –ê—É—Ç–æ—Ñ–∞–≥–∏—è ‚Üë | Longevity | ‚úÖ |
| –£—Ä–ª–∏—Ç–∏–Ω –ê | 500 –º–≥ | 7:30 | –ú–∏—Ç–æ—Ñ–∞–≥–∏—è ‚Üë | Mitopure, longevity | ‚úÖ |
| –§–∏—Å–µ—Ç–∏–Ω | 100 –º–≥ | 7:30 | –°–µ–Ω–æ–ª–∏—Ç–∏–∫ | Longevity (–∫—É—Ä—Å–∞–º–∏ –≤—ã—à–µ) | ‚úÖ |
| –°–µ–ª–µ–Ω | 200 –º–∫–≥ | 7:30 | T4‚ÜíT3 –∫–æ–Ω–≤–µ—Ä—Å–∏—è | –©–∏—Ç–æ–≤–∏–¥–∫–∞ | ‚úÖ |
| –ô–æ–¥ | 150 –º–∫–≥ | 7:30 | –°–∏–Ω—Ç–µ–∑ T3/T4 | –©–∏—Ç–æ–≤–∏–¥–∫–∞ | ‚úÖ |
| –¢–µ–ª–º–∏—Å–∞—Ä—Ç–∞–Ω | 40 –º–≥ | 7:30 | ARB + PPAR-Œ≥ | –ê–î, –º–µ—Ç–∞–±–æ–ª–∏–∑–º | ‚úÖ |

### –î–ù–ï–í–ù–û–ô –ë–õ–û–ö (12:00-14:00)

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –î–æ–∑–∞ | –í—Ä–µ–º—è | –ú–µ—Ö–∞–Ω–∏–∑–º | –¶–µ–ª—å | –°—Ç–∞—Ç—É—Å |
|----------|------|-------|----------|------|--------|
| –§–∞–º–æ—Ç–∏–¥–∏–Ω | 20 –º–≥ | 13:00 | H2 –±–ª–æ–∫–∞–¥–∞ | MCAS | ‚úÖ |
| –ë–µ—Ä–±–µ—Ä–∏–Ω | 500 –º–≥ | 13:00 | AMPK ‚Üë | –ú–µ—Ç–∞–±–æ–ª–∏–∑–º, –≥–ª—é–∫–æ–∑–∞ | ‚úÖ |

### –í–ï–ß–ï–†–ù–ò–ô/–ù–û–ß–ù–û–ô –ë–õ–û–ö (20:00-22:00)

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –î–æ–∑–∞ | –í—Ä–µ–º—è | –ú–µ—Ö–∞–Ω–∏–∑–º | –¶–µ–ª—å | –°—Ç–∞—Ç—É—Å |
|----------|------|-------|----------|------|--------|
| LDN | 4.5 –º–≥ | 22:00 | –û–ø–∏–æ–∏–¥–Ω–∞—è –º–æ–¥—É–ª—è—Ü–∏—è | –ù–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ, –∏–º–º—É–Ω–∏—Ç–µ—Ç | ‚úÖ |
| –ö–µ—Ç–æ—Ç–∏—Ñ–µ–Ω | 1 –º–≥ | 22:00 | Mast cell —Å—Ç–∞–±–∏–ª–∏–∑–∞—Ç–æ—Ä | MCAS + —Å–µ–¥–∞—Ü–∏—è | ‚úÖ |
| –ì–ª–∏—Ü–∏–Ω | 2 –≥ | 22:00 | NMDA –∫–æ-–∞–≥–æ–Ω–∏—Å—Ç | –°–æ–Ω, –Ω–µ–π—Ä–æ–ø—Ä–æ—Ç–µ–∫—Ü–∏—è | ‚úÖ |
| –ê–ø–∏–≥–µ–Ω–∏–Ω | 50 –º–≥ | 22:00 | CD38 –∏–Ω–≥–∏–±–∏—Ç–æ—Ä | NAD+ ‚Üë, —Å–æ–Ω | ‚úÖ |
| Cycloastragenol | 10-25 –º–≥ | 22:00 | –¢–µ–ª–æ–º–µ—Ä–∞–∑–∞ ‚Üë | Longevity | ‚úÖ |
| –ì—É–∞–Ω—Ñ–∞—Ü–∏–Ω XR | 1-2 –º–≥ | 22:00 | Œ±2A –∞–≥–æ–Ω–∏—Å—Ç | Yale –ø—Ä–æ—Ç–æ–∫–æ–ª, PFC | ‚úÖ |

### –ö–£–†–°–û–í–´–ï –ü–†–ï–ü–ê–†–ê–¢–´

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –î–æ–∑–∞ | –†–µ–∂–∏–º | –ú–µ—Ö–∞–Ω–∏–∑–º | –¶–µ–ª—å | –°—Ç–∞—Ç—É—Å |
|----------|------|-------|----------|------|--------|
| –†–∞–ø–∞–º–∏—Ü–∏–Ω | 4 –º–≥ | 1√ó/–Ω–µ–¥–µ–ª—é (–°–±) | mTORC1 –∏–Ω–≥–∏–±–∏—Ç–æ—Ä | Longevity, –∞—É—Ç–æ—Ñ–∞–≥–∏—è, –ª–µ–ø—Ç–∏–Ω | ‚úÖ |
| FOXO4-DRI | 2-5 –º–≥ –ø/–∫ | 3√ó/–Ω–µ–¥–µ–ª—é, 3-4 –Ω–µ–¥ | –°–µ–Ω–æ–ª–∏—Ç–∏–∫ (p53-FOXO4) | –£–¥–∞–ª–µ–Ω–∏–µ —Å–µ–Ω–µ—Å—Ü–µ–Ω—Ç–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫ | ‚úÖ |
| –≠–ø–∏—Ç–∞–ª–æ–Ω | 5-10 –º–≥ –ø/–∫ | 10-20 –¥–Ω–µ–π, 2√ó/–≥–æ–¥ | –¢–µ–ª–æ–º–µ—Ä–∞–∑–∞ ‚Üë | Longevity | ‚úÖ |
| NOR-BNI | 750 –º–∫–≥ –ø/–∫ | 1√ó/4-6 –Ω–µ–¥–µ–ª—å | Œ∫-–æ–ø–∏–æ–∏–¥–Ω—ã–π –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç | –ê–Ω—Ç–∏–∞–Ω–≥–µ–¥–æ–Ω–∏—è | ‚úÖ |
| Dihexa | 1-2 –º–≥ –∏–Ω—Ç—Ä–∞–Ω–∞–∑. | 2-4 –Ω–µ–¥–µ–ª–∏ –∫—É—Ä—Å | HGF/c-Met | –ü–∞–º—è—Ç—å, —Å–∏–Ω–∞–ø—Ç–æ–≥–µ–Ω–µ–∑ | ‚úÖ |
| VIP | –ü–æ –ø—Ä–æ—Ç–æ–∫–æ–ª—É | –ö—É—Ä—Å–∞–º–∏ | –ù–µ–π—Ä–æ–ø–µ–ø—Ç–∏–¥ | –ì–∏–ø–æ—Ç–∞–ª–∞–º—É—Å, –≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ | ‚úÖ |
| BPC-157 | 250-500 –º–∫–≥ –ø/–∫ | 6-8 –Ω–µ–¥–µ–ª—å | –ê–Ω–≥–∏–æ–≥–µ–Ω–µ–∑, —Ä–µ–ø–∞—Ä–∞—Ü–∏—è | –í–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ —Ç–∫–∞–Ω–µ–π | ‚úÖ |
| TB-500 | 2-2.5 –º–≥ –ø/–∫ | 2√ó/–Ω–µ–¥–µ–ª—é, 6-8 –Ω–µ–¥ | –°–∏—Å—Ç–µ–º–Ω–∞—è —Ä–µ–ø–∞—Ä–∞—Ü–∏—è | –í–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ | ‚úÖ |

### –ü–û –¢–†–ï–ë–û–í–ê–ù–ò–Æ

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –î–æ–∑–∞ | –ö–æ–≥–¥–∞ | –ú–µ—Ö–∞–Ω–∏–∑–º | –¶–µ–ª—å | –°—Ç–∞—Ç—É—Å |
|----------|------|-------|----------|------|--------|
| PRL-8-53 | 10 –º–≥ —Å—É–±–ª–∏–Ω–≥. | –ó–∞ 2—á –¥–æ –≤–∞–∂–Ω–æ–≥–æ | –•–æ–ª–∏–Ω + DA | –û—Å—Ç—Ä—ã–π –º–Ω–µ–º–æ–Ω–∏–∫ | ‚úÖ |
| ITPP | 100 –º–≥ | –ü–µ—Ä–µ–¥ —Ç—Ä–µ–Ω–∏—Ä–æ–≤–∫–æ–π | –û–∫—Å–∏–≥–µ–Ω–∞—Ü–∏—è —Ç–∫–∞–Ω–µ–π | Performance | ‚úÖ |

### –ì–ó–¢ (–ü–û–°–¢–û–Ø–ù–ù–û)

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –î–æ–∑–∞ | –ß–∞—Å—Ç–æ—Ç–∞ | –ú–µ—Ö–∞–Ω–∏–∑–º | –¶–µ–ª—å | –°—Ç–∞—Ç—É—Å |
|----------|------|---------|----------|------|--------|
| –¢–µ—Å—Ç–æ—Å—Ç–µ—Ä–æ–Ω —ç–Ω–∞–Ω—Ç–∞—Ç | 150 –º–≥ | 2√ó/–Ω–µ–¥–µ–ª—é | AR –∞–≥–æ–Ω–∏—Å—Ç | –ì–ó–¢ –±–∞–∑–∞ | ‚úÖ |
| –ü—Ä–∏–º–æ–±–æ–ª–∞–Ω | 200 –º–≥ | 2√ó/–Ω–µ–¥–µ–ª—é | AR –∞–≥–æ–Ω–∏—Å—Ç | –ê–Ω–∞–±–æ–ª–∏–∑–º | ‚úÖ |
| HCG | 500 IU | 2√ó/–Ω–µ–¥–µ–ª—é | –°—Ç–∏–º—É–ª—è—Ü–∏—è –õ–µ–π–¥–∏–≥–∞ | –Ø–∏—á–∫–∏, –ø—Ä–µ–≥–Ω–µ–Ω–æ–ª–æ–Ω | ‚úÖ |
| –ì–† (Genotropin) | 5 IU | –ï–∂–µ–¥–Ω–µ–≤–Ω–æ —É—Ç—Ä–æ–º | GH‚ÜíIGF-1 | –†–µ–∫–æ–º–ø–æ–∑–∏—Ü–∏—è, longevity | ‚úÖ |

---

## 3. –í–ó–ê–ò–ú–û–î–ï–ô–°–¢–í–ò–Ø

### –ö–†–ò–¢–ò–ß–ï–°–ö–ò–ï –í–ó–ê–ò–ú–û–î–ï–ô–°–¢–í–ò–Ø (–¢–†–ï–ë–£–Æ–¢ –í–ù–ò–ú–ê–ù–ò–Ø)

| –ü—Ä–µ–ø–∞—Ä–∞—Ç 1 | –ü—Ä–µ–ø–∞—Ä–∞—Ç 2 | –¢–∏–ø | –û–ø–∏—Å–∞–Ω–∏–µ | –†–µ—à–µ–Ω–∏–µ |
|------------|------------|-----|----------|---------|
| –ú–æ–∫–ª–æ–±–µ–º–∏–¥ (MAO-A) | MB (—Å–ª–∞–±—ã–π MAO-A) | ‚ö†Ô∏è –ê–¥–¥–∏—Ç–∏–≤–Ω—ã–π | –û–±–∞ –∏–Ω–≥–∏–±–∏—Ä—É—é—Ç MAO-A | MB —Å–Ω–∏–∂–µ–Ω –¥–æ 15-20 –º–≥ |
| –ú–æ–∫–ª–æ–±–µ–º–∏–¥ | D-Phenylalanine | ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | MAO-A ‚Üë –≤—Ä–µ–º—è –∂–∏–∑–Ω–∏ PEA | –ñ–µ–ª–∞–µ–º—ã–π —ç—Ñ—Ñ–µ–∫—Ç |
| –†–∞–ø–∞–º–∏—Ü–∏–Ω (CYP3A4) | –ö–≤–µ—Ä—Ü–µ—Ç–∏–Ω (CYP3A4‚Üì) | ‚ö†Ô∏è ‚Üë–†–∞–ø–∞–º–∏—Ü–∏–Ω | –ö–≤–µ—Ä—Ü–µ—Ç–∏–Ω ‚Üë —É—Ä–æ–≤–µ–Ω—å —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞ 30-50% | –î–æ–∑–∞ —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞ 4–º–≥ = —ç—Ñ—Ñ. 5.5-7–º–≥ |
| –†–∞–ø–∞–º–∏—Ü–∏–Ω (CYP3A4) | –ë–µ—Ä–±–µ—Ä–∏–Ω (CYP3A4‚Üì) | ‚ö†Ô∏è ‚Üë–†–∞–ø–∞–º–∏—Ü–∏–Ω | –ë–µ—Ä–±–µ—Ä–∏–Ω ‚Üë —É—Ä–æ–≤–µ–Ω—å —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞ | –ü—Ä–æ–ø—É—Å—Ç–∏—Ç—å –±–µ—Ä–±–µ—Ä–∏–Ω –≤ –¥–µ–Ω—å —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞ |
| –†–∞–ø–∞–º–∏—Ü–∏–Ω (CYP3A4) | –ì—Ä–µ–π–ø—Ñ—Ä—É—Ç | üî¥ –û–ü–ê–°–ù–û | –ì—Ä–µ–π–ø—Ñ—Ä—É—Ç ‚Üë —Ä–∞–ø–∞–º–∏—Ü–∏–Ω –¥–æ 3.5-7√ó | –ò–ó–ë–ï–ì–ê–¢–¨ –≥—Ä–µ–π–ø—Ñ—Ä—É—Ç –í–°–ï–ì–î–ê |
| LDN (Œº/Œ¥-–æ–ø–∏–æ–∏–¥) | NOR-BNI (Œ∫-–æ–ø–∏–æ–∏–¥) | ‚ö†Ô∏è –°–ª–æ–∂–Ω–∞—è | –†–∞–∑–Ω—ã–µ —Ä–µ—Ü–µ–ø—Ç–æ—Ä—ã, –Ω–æ —Å–≤—è–∑–∞–Ω—ã | –ú–æ–∂–Ω–æ –≤–º–µ—Å—Ç–µ, –º–æ–Ω–∏—Ç–æ—Ä–∏—Ç—å |
| ~~–°—É–≥–ª–∞—Ç~~ | ~~–¢–µ–ª–º–∏—Å–∞—Ä—Ç–∞–Ω~~ | ~~‚ö†Ô∏è –ê–î‚Üì~~ | ~~–û–±–∞ —Å–Ω–∏–∂–∞—é—Ç –ê–î~~ | **–ù–ï–ê–ö–¢–£–ê–õ–¨–ù–û ‚Äî –°—É–≥–ª–∞—Ç —É–±—Ä–∞–Ω** |
| ~~–°—É–≥–ª–∞—Ç~~ | ~~TRT~~ | ~~‚ö†Ô∏è –õ–µ–ø—Ç–∏–Ω‚Üì~~ | ~~–û–±–∞ –º–æ–≥—É—Ç —Å–Ω–∏–∂–∞—Ç—å –ª–µ–ø—Ç–∏–Ω~~ | **–ù–ï–ê–ö–¢–£–ê–õ–¨–ù–û ‚Äî –°—É–≥–ª–∞—Ç —É–±—Ä–∞–Ω** |
| –ì–† 5 IU | –†–∞–ø–∞–º–∏—Ü–∏–Ω | ‚ö†Ô∏è mTOR –ø–∞—Ä–∞–¥–æ–∫—Å | –ì–† ‚ÜëmTOR, —Ä–∞–ø–∞–º–∏—Ü–∏–Ω ‚ÜìmTOR | –†–∞–ø–∞–º–∏—Ü–∏–Ω –≤ –¥–µ–Ω—å –æ—Ç–¥—ã—Ö–∞ (–°–±) |

### –ü–û–õ–û–ñ–ò–¢–ï–õ–¨–ù–´–ï –°–ò–ù–ï–†–ì–ò–ò

| –ü—Ä–µ–ø–∞—Ä–∞—Ç 1 | –ü—Ä–µ–ø–∞—Ä–∞—Ç 2 | –¢–∏–ø | –ú–µ—Ö–∞–Ω–∏–∑–º | –≠—Ñ—Ñ–µ–∫—Ç |
|------------|------------|-----|----------|--------|
| –†–∞–ø–∞–º–∏—Ü–∏–Ω | –°–ø–µ—Ä–º–∏–¥–∏–Ω | ‚úÖ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | –û–±–∞ ‚Üë –∞—É—Ç–æ—Ñ–∞–≥–∏—é | –ö–ª–∏—Ä–µ–Ω—Å spike, longevity |
| –†–∞–ø–∞–º–∏—Ü–∏–Ω | –§–∏—Å–µ—Ç–∏–Ω | ‚úÖ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | mTOR + —Å–µ–Ω–æ–ª–∏–∑–∏—Å | –ö–æ–º–ø–ª–µ–º–µ–Ω—Ç–∞—Ä–Ω—ã–µ –º–µ—Ö–∞–Ω–∏–∑–º—ã |
| FOXO4-DRI | –§–∏—Å–µ—Ç–∏–Ω | ‚úÖ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | –†–∞–∑–Ω—ã–µ —Å–µ–Ω–æ–ª–∏—Ç–∏—á–µ—Å–∫–∏–µ –º–µ—Ö–∞–Ω–∏–∑–º—ã | –î–≤–æ–π–Ω–æ–π —É–¥–∞—Ä –ø–æ —Å–µ–Ω–µ—Å—Ü–µ–Ω—Ü–∏–∏ |
| FOXO4-DRI | –†–∞–ø–∞–º–∏—Ü–∏–Ω | ‚úÖ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | –£–¥–∞–ª–µ–Ω–∏–µ + –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞ | –ü–æ–ª–Ω—ã–π –∞–Ω—Ç–∏—Å–µ–Ω–µ—Å—Ü–µ–Ω—Ü |
| LDN | MCAS-—Å—Ç–µ–∫ | ‚úÖ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | –ò–º–º—É–Ω–æ–º–æ–¥—É–ª—è—Ü–∏—è + mast cell | Long COVID |
| –ì—É–∞–Ω—Ñ–∞—Ü–∏–Ω | NAC | ‚úÖ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | Yale –ø—Ä–æ—Ç–æ–∫–æ–ª | Brain fog Long COVID |
| –ú–æ–∫–ª–æ–±–µ–º–∏–¥ | ADCAPR | ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | MAO-A + DA/NE release | –ú–æ—Ç–∏–≤–∞—Ü–∏—è, —Ñ–æ–∫—É—Å |
| Ac-Semax-NH2 | Dihexa | ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | BDNF/NGF + HGF/c-Met | –ù–µ–π—Ä–æ—Ä–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏—è |
| Ac-Semax-NH2 | PE-22-28 | ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | –û–±–∞ ‚Üë BDNF (—Ä–∞–∑–Ω—ã–µ –ø—É—Ç–∏) | –ù–µ–π—Ä–æ–ø–ª–∞—Å—Ç–∏—á–Ω–æ—Å—Ç—å |
| NMN | –ê–ø–∏–≥–µ–Ω–∏–Ω | ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | NAD+ —Å–∏–Ω—Ç–µ–∑ + CD38‚Üì | –û–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è NAD+ |
| –ë–µ—Ä–±–µ—Ä–∏–Ω | ~~IF 16/8~~ | ~~‚úÖ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è~~ | ~~AMPK + –∫–µ—Ç–æ–Ω—ã~~ | **IF –û–¢–ú–ï–ù–Å–ù** |
| –§–µ—Ä–º–µ–Ω—Ç—ã (–ù–∞—Ç—Ç–æ+–°–µ—Ä—Ä–∞+–ë—Ä–æ–º) | NAC | ‚úÖ –°–∏–Ω–µ—Ä–≥–∏—è | –ü—Ä–æ—Ç–µ–æ–ª–∏–∑ + –≥–ª—É—Ç–∞—Ç–∏–æ–Ω | –ö–ª–∏—Ä–µ–Ω—Å spike |

---

## 4. –ú–ï–•–ê–ù–ò–ó–ú–´

### –ö–û–ì–ù–ò–¢–ò–í–ö–ê –ò –ü–ê–ú–Ø–¢–¨

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –ú–µ—Ö–∞–Ω–∏–∑–º –¥–ª—è –∫–æ–≥–Ω–∏—Ç–∏–≤–∫–∏ | –°–∏–ª–∞ —ç—Ñ—Ñ–µ–∫—Ç–∞ | –î–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å |
|----------|------------------------|--------------|-----------------|
| –ì—É–∞–Ω—Ñ–∞—Ü–∏–Ω XR | Œ±2A –∞–≥–æ–Ω–∏—Å—Ç ‚Üí ‚Üë PFC —Ñ—É–Ω–∫—Ü–∏—è, Yale –ø—Ä–æ—Ç–æ–∫–æ–ª | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| Ac-Semax-NH2 | BDNF ‚Üë1.4√ó, NGF ‚Üë, trkB ‚Üë2√ó | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ (–†–§) |
| Dihexa | HGF/c-Met ‚Üí —Å–∏–Ω–∞–ø—Ç–æ–≥–µ–Ω–µ–∑, –ø–∞–º—è—Ç—å | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê | Preclinical |
| PE-22-28 | 5-HT4 –∞–≥–æ–Ω–∏—Å—Ç ‚Üí BDNF ‚Üë | ‚≠ê‚≠ê‚≠ê‚≠ê | Preclinical |
| Meclofenoxate | ACh ‚Üë + –∞–Ω—Ç–∏–ª–∏–ø–æ—Ñ—É—Å—Ü–∏–Ω | ‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| Eutropoflavin | TrkB –∞–≥–æ–Ω–∏—Å—Ç ‚Üí BDNF-–º–∏–º–µ—Ç–∏–∫ | ‚≠ê‚≠ê‚≠ê‚≠ê | Preclinical |
| ADCAPR | DA + NE + AMPA –º–æ–¥—É–ª—è—Ü–∏—è | ‚≠ê‚≠ê‚≠ê‚≠ê | Preclinical |
| PRL-8-53 | –•–æ–ª–∏–Ω + DA ‚Üí –æ—Å—Ç—Ä–∞—è –ø–∞–º—è—Ç—å | ‚≠ê‚≠ê‚≠ê‚≠ê | 1 –∫–ª–∏–Ω–∏—á. (1978) |
| Mg L-Threonate | Mg –≤ –º–æ–∑–≥ ‚Üí —Å–∏–Ω–∞–ø—Ç–∏—á–µ—Å–∫–∞—è –ø–ª–∞—Å—Ç–∏—á–Ω–æ—Å—Ç—å | ‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| Ibudilast | PDE4‚Üì, –≥–ª–∏—è –º–æ–¥—É–ª—è—Ü–∏—è ‚Üí –Ω–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ‚Üì | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| MB | –ú–∏—Ç–æ—Ö–æ–Ω–¥—Ä–∏–∏ –º–æ–∑–≥–∞, –∞–Ω—Ç–∏–≤–∏—Ä—É—Å | ‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| NAC | –ì–ª—É—Ç–∞—Ç–∏–æ–Ω ‚Üë, –Ω–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ‚Üì (Yale) | ‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |

### –ú–û–¢–ò–í–ê–¶–ò–Ø –ò –ê–ù–ì–ï–î–û–ù–ò–Ø

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –ú–µ—Ö–∞–Ω–∏–∑–º –¥–ª—è –º–æ—Ç–∏–≤–∞—Ü–∏–∏ | –°–∏–ª–∞ —ç—Ñ—Ñ–µ–∫—Ç–∞ | –î–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å |
|----------|------------------------|--------------|-----------------|
| NOR-BNI | Œ∫-–æ–ø–∏–æ–∏–¥ –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç ‚Üí ‚Üì—Ç–æ—Ä–º–æ–∑ –Ω–∞ DA | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| –ú–æ–∫–ª–æ–±–µ–º–∏–¥ | MAO-A RIMA ‚Üí DA/NE/5-HT ‚Üë | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| ADCAPR | DA + NE release | ‚≠ê‚≠ê‚≠ê‚≠ê | Preclinical |
| D-Phenylalanine | PEA –ø—Ä–µ–∫—É—Ä—Å–æ—Ä (—Å MAO = –¥–ª–∏—Ç–µ–ª—å–Ω–æ) | ‚≠ê‚≠ê‚≠ê | –¢–µ–æ—Ä–µ—Ç–∏—á. |
| LDN | Rebound —ç–Ω–¥–æ—Ä—Ñ–∏–Ω–æ–≤ ‚Üí –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–µ | ‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |

### LONG COVID / SPIKE CLEARANCE

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –ú–µ—Ö–∞–Ω–∏–∑–º –ø—Ä–æ—Ç–∏–≤ Long COVID | –°–∏–ª–∞ —ç—Ñ—Ñ–µ–∫—Ç–∞ | –î–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å |
|----------|---------------------------|--------------|-----------------|
| LDN | –ò–º–º—É–Ω–æ–º–æ–¥—É–ª—è—Ü–∏—è, –Ω–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ‚Üì | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| –ì—É–∞–Ω—Ñ–∞—Ü–∏–Ω + NAC | Yale –ø—Ä–æ—Ç–æ–∫–æ–ª –¥–ª—è brain fog | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| –ù–∞—Ç—Ç–æ–∫–∏–Ω–∞–∑–∞ | –§–∏–±—Ä–∏–Ω–æ–ª–∏–∑, spike degradation | ‚≠ê‚≠ê‚≠ê‚≠ê | In vitro + –∫–ª–∏–Ω–∏—á. |
| –°–µ—Ä—Ä–∞–ø–µ–ø—Ç–∞–∑–∞ | –ü—Ä–æ—Ç–µ–æ–ª–∏–∑ spike | ‚≠ê‚≠ê‚≠ê | In vitro |
| –ë—Ä–æ–º–µ–ª–∞–π–Ω | –ü—Ä–æ—Ç–µ–æ–ª–∏–∑ spike (—Å–∏–Ω–µ—Ä–≥–∏—è —Å NAC) | ‚≠ê‚≠ê‚≠ê | In vitro |
| MCAS-—Å—Ç–µ–∫ (–≠—Ä–∏—É—Å+–§–∞–º–æ—Ç+–ö–µ—Ç–æ—Ç–∏—Ñ–µ–Ω) | Mast cell —Å—Ç–∞–±–∏–ª–∏–∑–∞—Ü–∏—è | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| –†–∞–ø–∞–º–∏—Ü–∏–Ω | –ê—É—Ç–æ—Ñ–∞–≥–∏—è ‚Üë ‚Üí –∫–ª–∏—Ä–µ–Ω—Å spike | ‚≠ê‚≠ê‚≠ê | –¢–µ–æ—Ä–µ—Ç–∏—á. |
| –°–ø–µ—Ä–º–∏–¥–∏–Ω | –ê—É—Ç–æ—Ñ–∞–≥–∏—è ‚Üë ‚Üí –∫–ª–∏—Ä–µ–Ω—Å spike | ‚≠ê‚≠ê‚≠ê | –¢–µ–æ—Ä–µ—Ç–∏—á. |
| Ibudilast | –ù–µ–π—Ä–æ–≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ‚Üì, –≥–ª–∏—è | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| MB | –ú–∏—Ç–æ—Ö–æ–Ω–¥—Ä–∏–∏, –∞–Ω—Ç–∏–≤–∏—Ä—É—Å | ‚≠ê‚≠ê‚≠ê | In vitro |

### LONGEVITY

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –ú–µ—Ö–∞–Ω–∏–∑–º longevity | –°–∏–ª–∞ —ç—Ñ—Ñ–µ–∫—Ç–∞ | –î–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å |
|----------|-------------------|--------------|-----------------|
| –†–∞–ø–∞–º–∏—Ü–∏–Ω | mTORC1‚Üì ‚Üí –∞—É—Ç–æ—Ñ–∞–≥–∏—è‚Üë, –¥–æ–∫–∞–∑–∞–Ω–Ω—ã–π –≥–µ—Ä–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ (–º—ã—à–∏ +23-26%) |
| FOXO4-DRI | –°–µ–ª–µ–∫—Ç–∏–≤–Ω—ã–π —Å–µ–Ω–æ–ª–∏—Ç–∏–∫, —É–¥–∞–ª–µ–Ω–∏–µ –∑–æ–º–±–∏-–∫–ª–µ—Ç–æ–∫ | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê | Preclinical (–º—ã—à–∏) |
| –§–∏—Å–µ—Ç–∏–Ω | –°–µ–Ω–æ–ª–∏—Ç–∏–∫ (—Ä–∞–∑–Ω—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –æ—Ç FOXO4-DRI) | ‚≠ê‚≠ê‚≠ê‚≠ê | Preclinical |
| –°–ø–µ—Ä–º–∏–¥–∏–Ω | –ê—É—Ç–æ—Ñ–∞–≥–∏—è‚Üë —á–µ—Ä–µ–∑ EP300 | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| NMN | NAD+‚Üë ‚Üí —Å–∏—Ä—Ç—É–∏–Ω—ã | ‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| –£—Ä–ª–∏—Ç–∏–Ω –ê | –ú–∏—Ç–æ—Ñ–∞–≥–∏—è‚Üë | ‚≠ê‚≠ê‚≠ê‚≠ê | –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ |
| –≠–ø–∏—Ç–∞–ª–æ–Ω | –¢–µ–ª–æ–º–µ—Ä–∞–∑–∞‚Üë | ‚≠ê‚≠ê‚≠ê | Preclinical |
| Cycloastragenol | –¢–µ–ª–æ–º–µ—Ä–∞–∑–∞‚Üë + –∏–º–º—É–Ω–æ–º–æ–¥—É–ª—è—Ü–∏—è | ‚≠ê‚≠ê‚≠ê | Preclinical |
| ~~–°—É–≥–ª–∞—Ç~~ | ~~AMPK‚Üë, mTOR‚Üì, SIRT1‚Üë, –∫–µ—Ç–æ–≥–µ–Ω–µ–∑~~ | ~~‚≠ê‚≠ê‚≠ê‚≠ê~~ | **–£–ë–†–ê–ù** |

---

## 5. –†–ò–°–ö–ò –ò –ú–û–ù–ò–¢–û–†–ò–ù–ì

### –ö–õ–Æ–ß–ï–í–´–ï –†–ò–°–ö–ò

| –†–∏—Å–∫ | –ü—Ä–∏—á–∏–Ω–∞ | –°–∏–º–ø—Ç–æ–º—ã | –î–µ–π—Å—Ç–≤–∏–µ |
|------|---------|----------|----------|
| –°–µ—Ä–æ—Ç–æ–Ω–∏–Ω–æ–≤—ã–π —Å–∏–Ω–¥—Ä–æ–º | MAO + —Ç—Ä–∏–ø—Ç–æ—Ñ–∞–Ω/5-HTP/–°–ò–û–ó–° | –¢—Ä–µ–º–æ—Ä, –≥–∏–ø–µ—Ä—Ç–µ—Ä–º–∏—è, —Ç–∞—Ö–∏–∫–∞—Ä–¥–∏—è | üî¥ –°–ö–û–†–ê–Ø. –ò–∑–±–µ–≥–∞—Ç—å –∫–æ–º–±–∏–Ω–∞—Ü–∏–π |
| –ì–∏–ø–µ—Ä—Ç–æ–Ω–∏—á–µ—Å–∫–∏–π –∫—Ä–∏–∑ | –†–∞–ø–∞–º–∏—Ü–∏–Ω + –≥—Ä–µ–π–ø—Ñ—Ä—É—Ç | –°–∏–ª—å–Ω–∞—è –≥–æ–ª–æ–≤–Ω–∞—è –±–æ–ª—å, —Ç–∞—Ö–∏–∫–∞—Ä–¥–∏—è | üî¥ –°–ö–û–†–ê–Ø. –ì—Ä–µ–π–ø—Ñ—Ä—É—Ç –ó–ê–ü–†–ï–©–Å–ù |
| ~~–≠—É–≥–ª–∏–∫–µ–º–∏—á–µ—Å–∫–∏–π –∫–µ—Ç–æ–∞—Ü–∏–¥–æ–∑~~ | ~~–°—É–≥–ª–∞—Ç + –∫–µ—Ç–æ + –±–æ–ª–µ–∑–Ω—å/–≥–æ–ª–æ–¥–∞–Ω–∏–µ~~ | ~~–¢–æ—à–Ω–æ—Ç–∞, —Ä–≤–æ—Ç–∞, —Å–ø—É—Ç–∞–Ω–Ω–æ—Å—Ç—å~~ | **–†–ò–°–ö –°–ù–Ø–¢ ‚Äî –°—É–≥–ª–∞—Ç —É–±—Ä–∞–Ω** |
| –ö—Ä–∏—Ç–∏—á–µ—Å–∫–æ–µ –ø–∞–¥–µ–Ω–∏–µ –ª–µ–ø—Ç–∏–Ω–∞ | TRT + ~~–°—É–≥–ª–∞—Ç~~ + –¥–µ—Ñ–∏—Ü–∏—Ç | –£—Å—Ç–∞–ª–æ—Å—Ç—å, —Ö–æ–ª–æ–¥, –≥–æ–ª–æ–¥ | –°—É–≥–ª–∞—Ç —É–±—Ä–∞–Ω, –º–æ–Ω–∏—Ç–æ—Ä–∏—Ç—å –ª–µ–ø—Ç–∏–Ω |
| ~~–ì–µ–Ω–∏—Ç–∞–ª—å–Ω—ã–µ –∏–Ω—Ñ–µ–∫—Ü–∏–∏~~ | ~~–°—É–≥–ª–∞—Ç ‚Üí –≥–ª—é–∫–æ–∑–∞ –≤ –º–æ—á–µ~~ | ~~–ó—É–¥, –≤—ã–¥–µ–ª–µ–Ω–∏—è~~ | **–†–ò–°–ö –°–ù–Ø–¢ ‚Äî –°—É–≥–ª–∞—Ç —É–±—Ä–∞–Ω** |
| –ò–º–º—É–Ω–æ—Å—É–ø—Ä–µ—Å—Å–∏—è | –†–∞–ø–∞–º–∏—Ü–∏–Ω –ø—Ä–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–∏ | –ó–∞—Ç—è–∂–Ω–∞—è –±–æ–ª–µ–∑–Ω—å | –ü—Ä–æ–ø—É—Å—Ç–∏—Ç—å —Ä–∞–ø–∞–º–∏—Ü–∏–Ω –ø—Ä–∏ –±–æ–ª–µ–∑–Ω–∏ |
| –ì–∏–ø–æ—Ç–æ–Ω–∏—è | –¢–µ–ª–º–∏—Å–∞—Ä—Ç–∞–Ω | –ì–æ–ª–æ–≤–æ–∫—Ä—É–∂–µ–Ω–∏–µ, —Å–ª–∞–±–æ—Å—Ç—å | –ú–æ–Ω–∏—Ç–æ—Ä–∏—Ç—å –ê–î |
| **–ù–û–í–û–ï: –ü–æ–ª–∏–ø—Ä–∞–≥–º–∞–∑–∏—è** | 45+ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –µ–∂–µ–¥–Ω–µ–≤–Ω–æ | –ù–µ–ø—Ä–µ–¥—Å–∫–∞–∑—É–µ–º—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã | –î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ ‚Üí —É–ø—Ä–æ—â–µ–Ω–∏–µ |
| **–ù–û–í–û–ï: MAO-A + —Å–∏–º–ø–∞—Ç–æ–º–∏–º–µ—Ç–∏–∫–∏** | –ú–æ–∫–ª–æ–±–µ–º–∏–¥ + MB + D-Phe | –ì–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏—è, —Ç–∞—Ö–∏–∫–∞—Ä–¥–∏—è | –ú–æ–Ω–∏—Ç–æ—Ä–∏—Ç—å –ê–î, –ø—É–ª—å—Å |

### –ü–õ–ê–ù –ú–û–ù–ò–¢–û–†–ò–ù–ì–ê

| –ê–Ω–∞–ª–∏–∑ | –ß–∞—Å—Ç–æ—Ç–∞ | –¶–µ–ª—å | –ß—Ç–æ –º–æ–Ω–∏—Ç–æ—Ä–∏–º |
|--------|---------|------|---------------|
| –õ–µ–ø—Ç–∏–Ω | **–°–ï–ô–ß–ê–° + —á–µ—Ä–µ–∑ 4 –Ω–µ–¥** | >2-3 –Ω–≥/–º–ª | –≠—Ñ—Ñ–µ–∫—Ç –æ—Ç–º–µ–Ω—ã –°—É–≥–ª–∞—Ç–∞ |
| fT3, fT4, –¢–¢–ì | **–°–ï–ô–ß–ê–°** | fT4 –≤–µ—Ä—Ö–Ω—è—è —Ç—Ä–µ—Ç—å –Ω–æ—Ä–º—ã | –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã–π –≥–∏–ø–æ—Ç–∏—Ä–µ–æ–∑ |
| –ö–æ—Ä—Ç–∏–∑–æ–ª —É—Ç—Ä–æ–º + –ê–ö–¢–ì | **–°–ï–ô–ß–ê–°** | –ù–æ—Ä–º–∞ | –ù–∞–¥–ø–æ—á–µ—á–Ω–∏–∫–æ–≤–∞—è –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç—å |
| –õ–∏–ø–∏–¥—ã (–¢–ì, –•–°) | –ß–µ—Ä–µ–∑ 4-6 –Ω–µ–¥ –ø–æ—Å–ª–µ —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞ | –ù–µ –∫—Ä–∏—Ç–∏—á–Ω—ã–π —Ä–æ—Å—Ç | –†–∞–ø–∞–º–∏—Ü–∏–Ω ‚Üë —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥—ã |
| –ì–ª—é–∫–æ–∑–∞ –Ω–∞—Ç–æ—â–∞–∫ | –ï–∂–µ–º–µ—Å—è—á–Ω–æ | <6 –º–º–æ–ª—å/–ª | –†–∞–ø–∞–º–∏—Ü–∏–Ω –≤–ª–∏—è–Ω–∏–µ |
| –ò–º–º—É–Ω–æ–≥—Ä–∞–º–º–∞ | –ß–µ—Ä–µ–∑ 3 –º–µ—Å –ø–æ—Å–ª–µ —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞ | –ë–µ–∑ —Å—É–ø—Ä–µ—Å—Å–∏–∏ | –í–ª–∏—è–Ω–∏–µ —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞ |
| –ì–µ–º–∞—Ç–æ–∫—Ä–∏—Ç | –ö–∞–∂–¥—ã–µ 6-8 –Ω–µ–¥ | <52% | TRT + ITPP –≤–ª–∏—è–Ω–∏–µ |
| IGF-1 | **–°–ï–ô–ß–ê–° + –∫–∞–∂–¥—ã–µ 3 –º–µ—Å** | 200-300 –Ω–≥/–º–ª | –ì–† –¥–æ–∑–∞ |
| –≠—Å—Ç—Ä–∞–¥–∏–æ–ª | –ö–∞–∂–¥—ã–µ 6-8 –Ω–µ–¥ | 20-35 –ø–≥/–º–ª | TRT + AI |
| –ê–õ–¢/–ê–°–¢ | **–°–ï–ô–ß–ê–° + –∫–∞–∂–¥—ã–µ 3 –º–µ—Å** | –ù–æ—Ä–º–∞ | –ü–µ—á–µ–Ω—å (–º–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤) |
| H. pylori | **–°–ï–ô–ß–ê–°** | –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–π | –ö–æ–Ω—Ç—Ä–æ–ª—å —ç—Ä–∞–¥–∏–∫–∞—Ü–∏–∏ |

---

## 6. –†–ï–ö–û–ú–ï–ù–î–ê–¶–ò–ò

### –ò–ó–ú–ï–ù–ï–ù–ò–Ø –í v12.0

| –ò–∑–º–µ–Ω–µ–Ω–∏–µ | –ü—Ä–∏—á–∏–Ω–∞ | –°—Ç–∞—Ç—É—Å |
|-----------|---------|--------|
| **–£–ë–†–ê–ù: –°—É–≥–ª–∞—Ç 50 –º–≥** | –£—Å—É–≥—É–±–ª—è–µ—Ç –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –Ω–∏–∑–∫–∏–π –ª–µ–ø—Ç–∏–Ω (<0.5 –Ω–≥/–º–ª) | ‚ùå –£–ë–†–ê–ù |
| **–£–ë–†–ê–ù: IF 16:8** | –ü—Ä–∏ –Ω–∏–∑–∫–æ–º –ª–µ–ø—Ç–∏–Ω–µ –∫–æ–Ω—Ç—Ä–ø—Ä–æ–¥—É–∫—Ç–∏–≤–µ–Ω | ‚ùå –£–ë–†–ê–ù |
| **–î–û–ë–ê–í–õ–ï–ù–û: –û–±—è–∑–∞—Ç–µ–ª—å–Ω–∞—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞** | –ë–∞–∑–æ–≤—ã–µ –∞–Ω–∞–ª–∏–∑—ã –Ω–µ –ø—Ä–æ–≤–µ–¥–µ–Ω—ã –∑–∞ 3 –≥–æ–¥–∞ | üî¥ –°–†–û–ß–ù–û |

### –í–û–ó–ú–û–ñ–ù–´–ï –î–û–ü–û–õ–ù–ï–ù–ò–Ø (–û–¢–õ–û–ñ–ï–ù–´)

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –ó–∞—á–µ–º | –ü—Ä–∏–æ—Ä–∏—Ç–µ—Ç | –°—Ç–∞—Ç—É—Å |
|----------|-------|-----------|--------|
| 7,8-DHF (–µ—Å–ª–∏ –Ω–µ—Ç Eutropoflavin) | TrkB –∞–≥–æ–Ω–∏—Å—Ç, BDNF-–º–∏–º–µ—Ç–∏–∫ | –í—ã—Å–æ–∫–∏–π | –ï—Å—Ç—å Eutropoflavin |
| P21 (BDNF –ø–µ–ø—Ç–∏–¥) | BDNF‚Üë, –Ω–µ–π—Ä–æ—Ä–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏—è | –°—Ä–µ–¥–Ω–∏–π | **–û–¢–õ–û–ñ–ï–ù–û –¥–æ –∞–Ω–∞–ª–∏–∑–æ–≤** |
| Selank | –ê–Ω–∫—Å–∏–æ–ª–∏—Ç–∏–∫ + BDNF | –°—Ä–µ–¥–Ω–∏–π | –ï—Å—Ç—å Semax |
| Cerebrolysin | –ù–µ–π—Ä–æ—Ç—Ä–æ—Ñ–∏–Ω—ã (–∫—É—Ä—Å–∞–º–∏) | –°—Ä–µ–¥–Ω–∏–π | **–û–¢–õ–û–ñ–ï–ù–û –¥–æ –∞–Ω–∞–ª–∏–∑–æ–≤** |
| HBOT –∫—É—Ä—Å | –û–∫—Å–∏–≥–µ–Ω–∞—Ü–∏—è –º–æ–∑–≥–∞, Long COVID | –í—ã—Å–æ–∫–∏–π | **–û–¢–õ–û–ñ–ï–ù–û –¥–æ –∞–Ω–∞–ª–∏–∑–æ–≤** |
| –û—Ä–µ–∫—Å–∏–Ω–æ–≤—ã–π –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç | –ê—Ä—Ö–∏—Ç–µ–∫—Ç—É—Ä–∞ —Å–Ω–∞ | –°—Ä–µ–¥–Ω–∏–π | **–û–¢–õ–û–ñ–ï–ù–û –¥–æ –∞–Ω–∞–ª–∏–∑–æ–≤** |

### –ß–¢–û –£–ë–†–ê–¢–¨ / –û–ü–¢–ò–ú–ò–ó–ò–†–û–í–ê–¢–¨

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –ü–æ—á–µ–º—É —É–±—Ä–∞—Ç—å/–∏–∑–º–µ–Ω–∏—Ç—å | –ó–∞–º–µ–Ω–∞ | –°—Ç–∞—Ç—É—Å |
|----------|------------------------|--------|--------|
| CJC-1295 + Ipamorelin | –ù–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã –ø—Ä–∏ —ç–∫–∑–æ–≥–µ–Ω–Ω–æ–º –ì–† 5IU | –£–±—Ä–∞—Ç—å | ‚úÖ –£–±—Ä–∞–Ω–æ |
| Bromantane | ADCAPR –ø—Ä–µ–≤–æ—Å—Ö–æ–¥–∏—Ç | ADCAPR | ‚úÖ –ó–∞–º–µ–Ω–µ–Ω–æ |
| CDP-Choline | Meclofenoxate –ª—É—á—à–µ | Meclofenoxate | ‚úÖ –ó–∞–º–µ–Ω–µ–Ω–æ |
| –ê–Ω–∏—Ä–∞—Ü–µ—Ç–∞–º | ADCAPR –¥–∞—ë—Ç AMPA | ADCAPR | ‚úÖ –ó–∞–º–µ–Ω–µ–Ω–æ |
| Lion's Mane | Eutropoflavin + Dihexa –º–æ—â–Ω–µ–µ | Eutropoflavin | ‚úÖ –ó–∞–º–µ–Ω–µ–Ω–æ |
| L-—Ç–∏—Ä–æ–∑–∏–Ω | D-Phenylalanine —Å MAO —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ | D-Phenylalanine | ‚úÖ –ó–∞–º–µ–Ω–µ–Ω–æ |
| DSIP –Ω–∞ –Ω–æ—á—å | –ú–æ–∂–µ—Ç –º–µ—à–∞—Ç—å —Å–Ω—É | –£–±—Ä–∞—Ç—å –≤—Ä–µ–º–µ–Ω–Ω–æ | –¢–µ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å |
| Sembragiline | –ï—Å—Ç—å –º–æ–∫–ª–æ–±–µ–º–∏–¥ (MAO-A –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ) | –û—Å—Ç–∞–≤–∏—Ç—å –∏–ª–∏ —É–±—Ä–∞—Ç—å | –û—Ü–µ–Ω–∏—Ç—å |
| **–°—É–≥–ª–∞—Ç** | **–£—Å—É–≥—É–±–ª—è–µ—Ç –Ω–∏–∑–∫–∏–π –ª–µ–ø—Ç–∏–Ω** | **–£–±—Ä–∞—Ç—å** | ‚ùå **–£–ë–†–ê–ù v12** |

### –ö–†–ò–¢–ò–ß–ù–´–ï –ù–ê–ü–û–ú–ò–ù–ê–ù–ò–Ø

- üî¥ **–ì–†–ï–ô–ü–§–†–£–¢ –ó–ê–ü–†–ï–©–Å–ù** –ø—Ä–∏ –ø—Ä–∏—ë–º–µ —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞!
- üî¥ ~~–ù–ï –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –°—É–≥–ª–∞—Ç –Ω–∞ –¥–µ—Ñ–∏—Ü–∏—Ç–µ –∫–∞–ª–æ—Ä–∏–π~~ ‚Üí **–°—É–≥–ª–∞—Ç –£–ë–†–ê–ù**
- üî¥ –†–∞–ø–∞–º–∏—Ü–∏–Ω –ü–†–û–ü–£–°–ö–ê–¢–¨ –ø—Ä–∏ –±–æ–ª–µ–∑–Ω–∏/–ø–µ—Ä–µ–¥ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–µ–π
- üî¥ –†–∞–ø–∞–º–∏—Ü–∏–Ω –ø—Ä–∏–Ω–∏–º–∞—Ç—å –≤ –î–ï–ù–¨ –û–¢–î–´–•–ê (–Ω–µ –≤ –¥–µ–Ω—å —Ç—Ä–µ–Ω–∏—Ä–æ–≤–∫–∏)
- üî¥ **–ù–ï –î–û–ë–ê–í–õ–Ø–¢–¨ –Ω–æ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–æ –ø–æ–ª—É—á–µ–Ω–∏—è –∞–Ω–∞–ª–∏–∑–æ–≤**
- ‚ö†Ô∏è –ë–µ—Ä–±–µ—Ä–∏–Ω –ü–†–û–ü–£–°–ö–ê–¢–¨ –≤ –¥–µ–Ω—å —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞
- ‚ö†Ô∏è MB —Å–Ω–∏–∂–µ–Ω –¥–æ 15-20 –º–≥ –∏–∑-–∑–∞ –º–æ–∫–ª–æ–±–µ–º–∏–¥–∞
- ‚ö†Ô∏è –ú–æ–Ω–∏—Ç–æ—Ä–∏—Ç—å –ª–µ–ø—Ç–∏–Ω —á–µ—Ä–µ–∑ 4 –Ω–µ–¥–µ–ª–∏ –ø–æ—Å–ª–µ –æ—Ç–º–µ–Ω—ã –°—É–≥–ª–∞—Ç–∞
- ‚ö†Ô∏è NOR-BNI –¥–µ–π—Å—Ç–≤—É–µ—Ç 3-6 –Ω–µ–¥–µ–ª—å ‚Äî –Ω–µ —á–∞—â–µ 1 —Ä–∞–∑–∞ –≤ 4-6 –Ω–µ–¥–µ–ª—å
- ‚úÖ –†–∞–ø–∞–º–∏—Ü–∏–Ω –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Å –∫–≤–µ—Ä—Ü–µ—Ç–∏–Ω–æ–º + —Ñ–∏—Å–µ—Ç–∏–Ω–æ–º –¥–ª—è —É—Å–∏–ª–µ–Ω–∏—è
- ‚úÖ –ö–µ—Ç–æ—Ç–∏—Ñ–µ–Ω –Ω–∞ –Ω–æ—á—å ‚Äî —Å–µ–¥–∞—Ü–∏—è –∫–∞–∫ –ø–ª—é—Å –¥–ª—è —Å–Ω–∞

---

## 7. –†–ê–°–ü–ò–°–ê–ù–ò–ï

### –ï–ñ–ï–î–ù–ï–í–ù–û–ï –†–ê–°–ü–ò–°–ê–ù–ò–ï

| –í—Ä–µ–º—è | –ß—Ç–æ –ø—Ä–∏–Ω–∏–º–∞—Ç—å |
|-------|---------------|
| 5:00 | –ì–† 5 IU (fasted) |
| 7:30 (—Å –∑–∞–≤—Ç—Ä–∞–∫–æ–º) | –ö–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã–π –±–ª–æ–∫: MB 15-20–º–≥, ADCAPR 50–º–≥, –ú–æ–∫–ª–æ–±–µ–º–∏–¥ 150–º–≥, D-Phe 700–º–≥, Meclofenoxate 300–º–≥, Eutropoflavin 10–º–≥, Ibudilast 10–º–≥, Mg L-Threonate 1000–º–≥ |
| 7:30 | –ü–µ–ø—Ç–∏–¥—ã –∏–Ω—Ç—Ä–∞–Ω–∞–∑–∞–ª—å–Ω–æ: Ac-Semax-NH2 300-600–º–∫–≥, Dihexa 1-2–º–≥ (–∫—É—Ä—Å–∞–º–∏), PE-22-28 500–º–∫–≥ |
| 7:30 | Anti-COVID: –≠—Ä–∏—É—Å 5–º–≥, –ù–∞—Ç—Ç–æ–∫–∏–Ω–∞–∑–∞ 4000FU, –°–µ—Ä—Ä–∞–ø–µ–ø—Ç–∞–∑–∞ 120000SPU, –ë—Ä–æ–º–µ–ª–∞–π–Ω 500–º–≥, NAC 600–º–≥, –ö–≤–µ—Ä—Ü–µ—Ç–∏–Ω 500–º–≥ |
| 7:30 | –ú–µ—Ç–∞–±–æ–ª–∏–∑–º: ~~–°—É–≥–ª–∞—Ç 50–º–≥~~ **–£–ë–†–ê–ù**, –¢–µ–ª–º–∏—Å–∞—Ä—Ç–∞–Ω 40–º–≥ |
| 7:30 | Longevity: NMN 500-1000–º–≥, –°–ø–µ—Ä–º–∏–¥–∏–Ω 10-15–º–≥, –£—Ä–ª–∏—Ç–∏–Ω –ê 500–º–≥, –§–∏—Å–µ—Ç–∏–Ω 100–º–≥ |
| 7:30 | –©–∏—Ç–æ–≤–∏–¥–∫–∞: –°–µ–ª–µ–Ω 200–º–∫–≥, –ô–æ–¥ 150–º–∫–≥ |
| 13:00 | –§–∞–º–æ—Ç–∏–¥–∏–Ω 20–º–≥, –ë–µ—Ä–±–µ—Ä–∏–Ω 500–º–≥ (–ù–ï –≤ –¥–µ–Ω—å —Ä–∞–ø–∞–º–∏—Ü–∏–Ω–∞) |
| 16:00 (–æ–ø—Ü.) | ITPP 100–º–≥ –ø–µ—Ä–µ–¥ —Ç—Ä–µ–Ω–∏—Ä–æ–≤–∫–æ–π |
| 22:00 | –°–æ–Ω-—Å—Ç–µ–∫: LDN 4.5–º–≥, –ö–µ—Ç–æ—Ç–∏—Ñ–µ–Ω 1–º–≥, –ì–ª–∏—Ü–∏–Ω 2–≥, –ê–ø–∏–≥–µ–Ω–∏–Ω 50–º–≥, Cycloastragenol 10-25–º–≥, –ì—É–∞–Ω—Ñ–∞—Ü–∏–Ω XR 1-2–º–≥ |
| –°—É–±–±–æ—Ç–∞ —É—Ç—Ä–æ–º | –†–∞–ø–∞–º–∏—Ü–∏–Ω 4–º–≥ + –ö–≤–µ—Ä—Ü–µ—Ç–∏–Ω 500-1000–º–≥ + –§–∏—Å–µ—Ç–∏–Ω 500–º–≥ (–¥–µ–Ω—å –æ—Ç–¥—ã—Ö–∞!) |

### –†–ï–ñ–ò–ú –ü–ò–¢–ê–ù–ò–Ø

| –ë—ã–ª–æ | –°—Ç–∞–ª–æ |
|------|-------|
| IF 16:8 (–æ–∫–Ω–æ 12:00-20:00) | **3 –ø—Ä–∏—ë–º–∞ –ø–∏—â–∏ –±–µ–∑ –æ–∫–Ω–∞** |
| ‚Ü≥ –ü—Ä–∏—á–∏–Ω–∞ | –ü—Ä–∏ –ª–µ–ø—Ç–∏–Ω–µ <0.5 IF –∫–æ–Ω—Ç—Ä–ø—Ä–æ–¥—É–∫—Ç–∏–≤–µ–Ω |

### –ö–£–†–°–û–í–´–ï

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –†–µ–∂–∏–º |
|----------|-------|
| FOXO4-DRI | 2-5–º–≥ –ø/–∫, 3√ó/–Ω–µ–¥–µ–ª—é, –∫—É—Ä—Å 3-4 –Ω–µ–¥–µ–ª–∏ ‚Üí –ø–µ—Ä–µ—Ä—ã–≤ |
| –≠–ø–∏—Ç–∞–ª–æ–Ω | 5-10–º–≥ –ø/–∫ –µ–∂–µ–¥–Ω–µ–≤–Ω–æ, 10-20 –¥–Ω–µ–π, 2 —Ä–∞–∑–∞ –≤ –≥–æ–¥ |
| NOR-BNI | 750–º–∫–≥ –ø/–∫ –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ, –ø–æ–≤—Ç–æ—Ä—è—Ç—å —á–µ—Ä–µ–∑ 4-6 –Ω–µ–¥–µ–ª—å |
| Dihexa | 1-2–º–≥ –∏–Ω—Ç—Ä–∞–Ω–∞–∑–∞–ª—å–Ω–æ –µ–∂–µ–¥–Ω–µ–≤–Ω–æ, –∫—É—Ä—Å 2-4 –Ω–µ–¥–µ–ª–∏ |
| BPC-157 + TB-500 | BPC 250-500–º–∫–≥ –µ–∂–µ–¥–Ω–µ–≤–Ω–æ + TB 2–º–≥ 2√ó/–Ω–µ–¥–µ–ª—é, –∫—É—Ä—Å 6-8 –Ω–µ–¥–µ–ª—å |

### –ì–ó–¢

| –ü—Ä–µ–ø–∞—Ä–∞—Ç | –†–µ–∂–∏–º |
|----------|-------|
| –¢–µ—Å—Ç–æ—Å—Ç–µ—Ä–æ–Ω —ç–Ω–∞–Ω—Ç–∞—Ç | 150–º–≥ 2√ó/–Ω–µ–¥–µ–ª—é (–ü–Ω+–ß—Ç) |
| –ü—Ä–∏–º–æ–±–æ–ª–∞–Ω | 200–º–≥ 2√ó/–Ω–µ–¥–µ–ª—é |
| HCG | 500 IU 2√ó/–Ω–µ–¥–µ–ª—é |
| –ê–Ω–∞—Å—Ç—Ä–æ–∑–æ–ª | 0.25-0.5–º–≥ –ø–æ E2 (–ø—Ä–∏ —Å–∏–º–ø—Ç–æ–º–∞—Ö –∏–ª–∏ E2>50) |

---

## –û–ë–Ø–ó–ê–¢–ï–õ–¨–ù–´–ï –ê–ù–ê–õ–ò–ó–´ –ü–ï–†–ï–î –°–õ–ï–î–£–Æ–©–ò–ú –¶–ò–ö–õ–û–ú

```
MUST HAVE:
1. –õ–µ–ø—Ç–∏–Ω
2. fT3, fT4, –¢–¢–ì
3. –ö–æ—Ä—Ç–∏–∑–æ–ª —É—Ç—Ä–æ–º (8:00)
4. –ê–ö–¢–ì
5. –¢–µ—Å—Ç–æ—Å—Ç–µ—Ä–æ–Ω –æ–±—â–∏–π + —Å–≤–æ–±–æ–¥–Ω—ã–π
6. SHBG
7. –≠—Å—Ç—Ä–∞–¥–∏–æ–ª
8. IGF-1
9. –ê–õ–¢, –ê–°–¢, –ì–ì–¢
10. –û–ê–ö —Å –≥–µ–º–∞—Ç–æ–∫—Ä–∏—Ç–æ–º
11. H. pylori (–¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã–π —Ç–µ—Å—Ç –∏–ª–∏ –∫–∞–ª –Ω–∞ –∞–Ω—Ç–∏–≥–µ–Ω)

NICE TO HAVE:
- EBV VCA IgM/IgG, EA IgG
- –¢—Ä–∏–ø—Ç–∞–∑–∞
- –°–†–ë, IL-6
- –ê–¥–∏–ø–æ–Ω–µ–∫—Ç–∏–Ω
```

---

## –ò–°–¢–û–†–ò–Ø –í–ï–†–°–ò–ô

| –í–µ—Ä—Å–∏—è | –î–∞—Ç–∞ | –ò–∑–º–µ–Ω–µ–Ω–∏—è |
|--------|------|-----------|
| v11.0 | ‚Äî | Baseline |
| **v12.0** | 2026-01-22 | –£–±—Ä–∞–Ω –°—É–≥–ª–∞—Ç, —É–±—Ä–∞–Ω IF, –¥–æ–±–∞–≤–ª–µ–Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–∞—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ |
